Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease

Citation
B. Polack et al., Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease, BIOC BIOP R, 275(3), 2000, pp. 854-858
Citations number
26
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
275
Issue
3
Year of publication
2000
Pages
854 - 858
Database
ISI
SICI code
0006-291X(20000907)275:3<854:PDBPTI>2.0.ZU;2-Q
Abstract
Bacterial type III secretion system drives the translocation of virulence f actors into the cystosol of host target cells. In phagocytes and in Epstein -Barr virus immortalized B lymphocytes, NADPH oxidase generates O-2(-) thro ugh an electron transfer chain the activity of which depends on the assembl y of three, p67(phox), p47(phox) and p40(phox) cytosolic activating factors with Rac 1/2 and a membrane redox component, cytochrome b(558). In p67(pho x) deficient chronic granulomatous disease (CGD) patients, p67-phox is miss ing and NADPH oxidase activity is abolished. ExoS is a virulence factor of Pseudomonas aeruginosa which is secreted via the type III secretion system: it was fused with p67(phox). Pseudomonas aeruginosa synthesized and transl ocated the hybrid ExoS-p67(phox) fusion protein into the cytosol of B lymph ocytes via the type III secretion system. Purified ExoS-p67(phox) hybrid pr otein was as efficient as normal recombinant p67(phox) cell-free reconstitu tion of NADPH oxidase activity. Therefore, ExoS-p67(phox) was transferred v ia the type III secretion system of Pseudomonas aeruginosa into the cytosol of B lymphocytes from a p67(phox)-deficient CGD patient and functionally r econstituted NADPH oxidase activity. In the complementation process,ExoS ac ted as a molecular courier for protein delivery: the reconstitution of an a ctive NADPH oxidase complex suggests type III secretion system to be a new approach for cellular therapy. (C) 2000 Academic Press.